Invasive aspergillosis is a serious infectious complication after allogeneic stem cell transplantation. One of the strategies to improve the management of aspergillosis is the adoptive transfer of antigen-specific T cells, the success of which depends on the development of a broad repertoire of antigen-specific T cells. In this study, we identified CD4+ T cells specific for the Aspergillus proteins Crf1 and catalase 1 in 18 of 24 healthy donors by intracellular staining for interferon γ and CD154. Crf1-and catalase 1-specific T cells were selected on the basis of CD137 expression and underwent single-cell expansion. Aspergillus-specific T-cell clones mainly exhibited a T-helper cell 1 phenotype and recognized a broad variety of T-cell epitopes. Five novel Crf1 epitopes, 2 previously described Crf1 epitopes, and 30 novel catalase 1 epitopes were identified. Ultimately, by using overlapping peptides of Aspergillus fumigatus proteins, Aspergillus-specific T-cell lines that have a broad specificity and favorable cytokine profile and are suitable for adoptive T-cell therapy can be generated in vitro.
Aspergillosis is a common infectious complication in patients with hematological malignancies and those have undergone allogeneic stem cell transplantation (SCT) [1, 2] . There is increasing evidence that, besides the well-established risk factor neutropenia [3] , impaired T-cell immune reconstitution is an important risk factor for invasive aspergillosis [4] [5] [6] .
To improve the outcome of patients after SCT and reduce the morbidity and mortality of Aspergillus infections, adoptive T-cell therapy for aspergillosis may be beneficial. In murine studies of vaccination with Aspergillus fumigatus recombinant proteins [7, 8] , the adoptive transfer of antigen-pulsed dendritic cells (DCs) [8, 9] or splenic CD4+ T cells, which were obtained after in vivo stimulation with A. fumigatus crude culture antigens [5, 9] , resulted in a prolonged survival of Aspergillusinfected mice and a reduced fungal burden. In humans, it was shown that patients with aspergillosis after haploidentical SCT have a better prognosis after undergoing transfer with T-cell lines generated by stimulating peripheral blood mononuclear cells (PBMCs) with A. fumigatus conidia [10] .
When generating a T-cell product by stimulating with Aspergillus crude extract or recombinant protein, the specificity of the T-cell line is difficult to establish. Furthermore, a considerable variation between different batches of crude extracts and recombinant proteins can be expected. To avoid these complicating factors, another option for the generation of an Aspergillus-specific T-cell product is by stimulating with peptides of A. fumigatus proteins. Until now, however, few T-cell epitopes of only the Crf1 protein have been published [11] [12] [13] .
To get more insight into which A. fumigatus peptides should be used to generate a T-cell product with immunological activity against A. fumigatus, it is important to study the diversity of the Aspergillus-specific T-cell repertoire. Furthermore, it is essential to gain knowledge of the variety of cytokine profiles of Aspergillus-specific T cells before considering infusion of Aspergillusspecific T cells in patients with invasive aspergillosis. We studied the immune response against Crf1 and catalase 1, because in previous studies that used recombinant proteins T cells directed against Crf1 displayed a T-helper cell 1 (Th1) phenotype and T cells directed against catalase 1 displayed a more T-helper cell 2 (Th2) phenotype [6, 8] . Furthermore, Crf1 and catalase 1 are differentially expressed: Crf1 is present in both conidia and hyphae, whereas catalase 1 is only present in Aspergillus hyphae.
By stimulating T cells with overlapping peptides of Crf1 and catalase 1, we show that low frequencies of both Crf1-and catalase 1-specific T cells with a Th1 phenotype directed against a broad variety of T-cell epitopes are present in healthy individuals. Because we identified Aspergillus-specific T cells specific for Crf1 and catalase 1, this suggests that the T-cell-mediated immune response against A. fumigatus is directed against multiple Aspergillus proteins.
MATERIALS AND METHODS

Aspergillus Antigens and Synthetic Peptides
Overlapping peptides of the Aspergillus proteins Crf1 and catalase 1, consisting of 15mer peptides with an 11-amino acid overlap, were synthesized by JPT Peptide Technologies (Berlin, Germany). Peptides were divided into a complete pool, subpools of 8-12 peptides and 96 single peptides for Crf1, and 180 single peptides for catalase 1. To confirm specificity, synthetic peptides were made at the Leiden University Medical Center (LUMC, Leiden, Netherlands).
For the production of catalase 1 recombinant protein, 3 catalase 1 fragments were generated with a 12-amino acid overlap. The fragments were cloned into pDon221 and, following sequencing, were cloned into Gateway (Invitrogen, Bleiswijk, Netherlands) bacterial expression vector pDEST17. Vectors were transformed into Escherichia coli BL21, and protein expression was induced by 1 mM IPTG (Promega, Leiden, Netherlands). Recombinant protein was isolated by purification of inclusion bodies.
For the preparation of Aspergillus crude extract, conidia of A. fumigatus strain CBS 144.89 (10 6 /mL) were cultured in 70 mL of liquid complete medium and gently shaken at 37°C overnight. The mycelium was ground in the presence of liquid nitrogen, and protein extraction buffer was added. Protein content was measured by the Bio-Rad technique. Furthermore, commercially available crude extracts of the A. fumigatus strains CBS 192.65 (HAL Allergy, Leiden, Netherlands) and CBS 545.65 (Allergon, Angelholm, Sweden) were used.
Enzyme-Linked Immunosorbent Spot (Elispot) Assay
All studies were conducted with approval of the institutional review board of the LUMC. After informed consent was given in accordance with the Declaration of Helsinki, peripheral blood was obtained from healthy donors, and PBMCs were isolated by Ficoll-Isopaque separation and cryopreserved. PBMCs (2 × 10 6 ) were cultured for 48 hours in a 24-well plate in the presence or absence of the Crf1 or catalase 1 complete pool (10 −6 M). 
Generation of T-Cell Clones
We selected Aspergillus-specific T cells on the basis of CD137 expression 48 hours after stimulation and restimulation, as described above. Cells were stained with allophycocyanin-labeled anti-CD137 (BD/Pharmingen) and peridinin chlorophyll proteinlabeled anti-CD4 and sorted by FACS. To generate T-cell clones, cells were sorted at 1 cell per well into a U-bottomed microtiter plate containing 100 μL of feeder mixture, consisting of T-cell medium, phytohemagglutinin (800 ng/mL), and irradiated allogeneic PBMCs (0.5 × 10 6 /mL). Fresh T-cell medium was added after 7 days, and T-cell clones were restimulated every 3-4 weeks with irradiated allogeneic PBMCs (10 6 /mL) and phytohemagglutinin (800 ng/mL) in a ratio of responder to stimulator (R:S) of 1:5.
Vβ Analysis of T-Cell Clones
To determine Vβ use by the T-cell clones, the IOTest Beta Mark T-cell receptor (TCR) kit (Beckman Coulter) was used, according to the manufacturer's instructions. For a selection of T-cell clones, the TCR Vβ was analyzed by reverse transcription polymerase chain reaction (RT-PCR) and sequencing.
Determination of Specificity and Epitope Identification
To determine specificity, proliferating T-cell clones were stimulated overnight with autologous PBMCs (R: To confirm the identified epitopes, the clones were tested with newly produced synthetic peptides (LUMC).
To determine Aspergillus specificity, peptide-specific clones were stimulated overnight with autologous EBV-LCLs (R:S, 1:4) loaded with recombinant protein (100 μg/mL) or with autologous monocyte-derived DCs preloaded with Aspergillus crude extract (R:S, 1:4). Monocyte-derived DCs were generated as previously described [14] .
Determination of HLA Restriction
To determine the HL restriction of the T-cell clones, autologous EBV-LCLs or autologous PBMCs were loaded with the single peptide (10 −6 M) and incubated for 2 hours. After thorough washing, the stimulator cells, monoclonal antibodies specific for HLA class II (PdV5.2), HLA-DR (B8.11.2), HLA-DQ (SPVL3), HLA-DP (B7.21), or the HLA-DR antigens DRB3*02 (TL2C9) or DRB1*11 (VR1H5), were added and incubated for 1 hour. Subsequently, T cells were added in an R:S of 1:4 and incubated overnight. Supernatant was analyzed using standard ELISA.
Further determination of the HLA restriction was analyzed using an HLA-typed EBV-LCL panel, containing partially matched allogeneic EBV-LCLs. T-cell clones and EBV-LCLs (R:S, 1:4) were incubated overnight with the complete overlapping peptide pool (10 −6 M), and the supernatant was tested in ELISA. To confirm
HLA restriction, clones were tested by loading the peptide pool on HLA class II-negative HeLa cells that were transduced with the HLA-DR, -DQ, or -DP molecules expressed by the individuals from whom the T-cell clones were derived, as previously described [15] .
RESULTS
Low Frequencies of Crf1-and Catalase 1-Specific T Cells Are Present in Healthy Individuals
To When we analyzed the frequencies of Aspergillus-specific T cells in PBMCs from 24 healthy donors by flow cytometry, we could not detect Aspergillus-specific T cells directly ex vivo on the basis of IFN-γ production or expression of the activation markers CD154 or CD137 (data not shown). To increase the sensitivity, we expanded the Aspergillus-specific T cells in vitro, using a restimulation protocol. Frequencies of Aspergillusspecific T cells after restimulation were calculated by subtracting the percentage of IFN-γ+CD154+ cells among CD4+ T cells after restimulation with unloaded PBMCs from the percentage of IFN-γ+CD154+ cells among CD4+ T cells after restimulation with PBMCs loaded with overlapping peptide pools ( Table 1) . A frequency of 0.05% IFN-γ+CD154+ cells among CD4+ T cells was considered relevant. In Figure 2A and 2B, 2 representative examples of flow cytometry findings for donors with high frequencies and low frequencies of Aspergillus-specific T cells are shown. Overall, IFNγ+CD154+ T cells specific for Crf1 or catalase 1, with a frequency ranging from 0.05% to 0.4% of CD4+ T cells, were demonstrated in 18 of the 24 healthy donors (Table 1) .
Crf1-and Catalase 1-Specific T Cells Recognize a Broad Variety of Aspergillus Epitopes and Are Predominantly of the Th1 Phenotype
To identify the recognized T-cell epitopes and determine the cytokine profiles of the Crf1-and catalase 1-specific T cells, Aspergillus-specific CD4+ T cells from 9 donors were single-cell sorted on the basis of CD137 expression, using the restimulation protocol. Twenty-five Crf1-and 52 catalase 1-specific Tcell clones were isolated from 8 of the 9 donors. Twenty-one Crf1-specific T-cell clones produced IFN-γ, of which 16 (76%) also produced low levels of IL-4, IL-10, or IL-17. The other 4 Crf1-specific clones only produced IL-4 and no other cytokines. Forty-nine of the 52 catalase 1-specific T-cell clones produced IFN-γ, of which 32 (65%) also produced low levels of IL-4, IL-10, or IL-17. The other 3 catalase 1-specific clones only produced IL-4 and no other cytokines. There were no Aspergillus-specific T-cell clones that produced IL-10 or IL-17 without IFN-γ production (data not shown). A selection of clones was tested for the production of other cytokines in the Bio-plex Pro 17-plex Luminex assay (Bio-Rad). Production of IL-5 and IL-13 was detected, which was restricted to clones that produced IL-4 (data not shown).
The recognized epitopes were identified by measuring IFN-γ or IL-4 production after stimulating the T-cell clones with the subpools of overlapping Crf1 or catalase 1 peptides; subpools are presented in a matrix ( Figure 3A) . Every peptide was only present in 2 subpools, which enabled us to identify the target peptide directly from the subpool analysis. An example is shown in Figure 3B . T-cell clone ZBE5 recognized the Crf1 subpools 4, 5, and D and, therefore, recognized the peptides D4 (amino acids 157-171) and D5 (amino acids 161-175), as can be derived from the matrix in Figure 3A . The T-cell epitope is the 11-amino acid overlap between these 2 peptides (amino acids 161-171; HTYTIDWTKDA), which was confirmed by stimulating the clone with newly synthesized peptide ( Figure 3C ). All identified T-cell epitopes were confirmed in this way, and amino acid sequences of the epitopes and their position in the Crf1 or catalase 1 protein are listed in Table 2 . TCR Vβ use was analyzed by flow cytometry, using the TCR Vβ kit, and, in some cases, by RT-PCR and sequencing, and results are also presented in Table 2 .
HLA restrictions of the T-cell clones were characterized using blocking monoclonal antibodies, an HLA-typed EBV-LCL panel, and HLA class II-transduced HeLa cell-lines, and the results of 2 representative examples are presented in Figure 4 . IFN-γ production by clone ZBE5 was reduced with HLA class II and HLA-DR antibodies and by clone UTL20 after blocking with HLA-DQ antibodies ( Figure 4A ). For further determination of the HLA restriction, the clones were stimulated with a peptide-loaded HLA-typed EBV-LCL panel. Clone ZBE5 recognized the Crf1 peptide HTY (amino acids 161-171) when loaded on a DRB3*01 EBV-LCL, and clone UTL20 recognized the catalase 1 peptide KEG (amino acids 129-143) when loaded on a DQB1*0602 EBV-LCL ( Figure 4B ). HLA restriction was confirmed by stimulating the clones with peptide-loaded HeLa cells transduced with different HLA-DR, -DQ, or -DP molecules ( Figure 4C ). The HLA restrictions of all identified epitopes are summarized in Table 2 .
We considered T cells of the same clonal origin, when T-cell clones were generated from 1 individual, had similar TCR Vβ use on the basis of TCR Vβ monoclonal antibody analysis, and recognized 1 epitope presented by the same HLA molecule. Overall, of the 25 Crf1-specific T-cell clones, 9 were unique clones, originating from 4 different donors and recognizing 7 different Crf1 epitopes; and of the 52 catalase 1-specific T-cell clones, 36 were unique clones, originating from 7 different donors and recognizing 30 different catalase 1 epitopes. The majority of the epitopes are presented by HLA-DR, although some epitopes are HLA-DQ or HLA-DP restricted ( Table 2) .
Reactivity of Crf1-and Catalase 1-Specific T Cells to Aspergillus Protein Extract and Recombinant Protein Is Dependent on the Avidity of the T-Cell Clone
To prove Aspergillus specificity, clones were stimulated with DCs loaded with Aspergillus protein extract or EBV-LCLs loaded with Aspergillus recombinant protein, and cytokine production was analyzed. Of the 9 Crf1-specific T-cell clones with 7 different peptide specificities, 8 clones recognizing 6 different epitopes were reactive to autologous DCs loaded with protein extract ( Figure 5A and Table 2 ). Of the 36 catalase 1-specific T-cell clones with 30 different peptide specificities, only 2 clones recognizing 2 different epitopes were reactive to autologous DCs loaded with Aspergillus protein extract. However, when we tested the catalase 1-specific T-cell clones against autologous EBV-LCLs loaded with catalase 1 recombinant protein, IFN-γ production was seen in 22 of the 36 catalase 1-specific T-cell clones, covering 20 different epitopes. The reactivities to Aspergillus protein extract and catalase 1 recombinant protein in a representative selection of catalase 1-specific clones are presented in Figure 5B and 5C, respectively. The results for all clones are presented in Table 2 . Only the catalase 1-specific T-cell clones with the highest avidity recognize the Aspergillus crude extract, as is demonstrated by the differences in recognition between clones 3, 8, 14, and 17, derived from donor GHK. These clones all recognize catalase 1 peptide GKM (amino acids 345-359) presented by HLA-DRB3*0202. TCR Vβ analysis revealed that GHK clones 3, 8, 14, and 17 all used a different Vβ TCR ( Table 2) . Titration of peptide and recombinant protein, as shown in Figure 5D and 5E, respectively, demonstrated that catalase 1 clone 8 from donor GHK that is reactive to the Aspergillus crude extract has the highest avidity, in contrast to the nonreactive clones 3 and 17. Clone 14 from donor GHK showed very low or no recognition of the protein extract ( Figure 5B ) but showed IFN-γ production after stimulation with EBV-LCLs loaded with catalase 1 recombinant protein ( Figure 5C ). This clone is also a highavidity T-cell clone but needs more peptide than GHK clone 8 for stimulation, as is demonstrated by loading EBV-LCLs with titrated concentrations of peptide ( Figure 5D ) and catalase 1 recombinant protein ( Figure 5E ).
DISCUSSION
In this study, we demonstrate the presence of low frequencies of Aspergillus-specific T cells directed against the A. fumigatus proteins Crf1 and catalase 1 in healthy individuals. These T cells recognize a diverse repertoire of T-cell epitopes presented in different HLA class II molecules. The Aspergillus-specific Tcell clones isolated on the basis of CD137 expression are predominantly of the Th1 phenotype, producing high amounts of IFN-γ and no or low amounts of the cytokines IL-4, IL-10, and IL-17. Aspergillus reactivity was confirmed for the majority of the Crf1-specific T-cell clones, by stimulating the T cells with DCs loaded with Aspergillus protein extract, and for the majority of catalase 1-specific T cells, by stimulating with EBV-LCLs loaded with recombinant protein.
In previous studies, the presence of Aspergillus-specific T cells in healthy individuals was shown by stimulating PBMCs with Aspergillus protein extracts [6, 16, 17] , A. fumigatus conidia or hyphae [6] , or A. fumigatus recombinant proteins [6, 8, 18] . Interferon γ (IFN-γ) production was measured after overnight incubation. B, Clone ZBE5 and UTL20 were stimulated with Crf1 or catalase 1 peptide mixture-loaded EBV-LCLs expressing ≥1 HLA-DR or HLA-DQ molecule corresponding to the HLA type of the individual from whom the T-cell clone was derived, as indicated in bold. The HLA restriction molecule used for presentation of these epitopes is underlined. C, HLA restriction of Crf1-and catalase 1-specific clones was confirmed by testing with peptide-loaded HLA class II-transduced HeLa cells. T-cell clone ZBE5 was isolated from an individual with HLA-DR type DRB1*0301, DRB1*04, DRB3*01, and DRB4*01. T-cell clone UTL20 was isolated from an individual homozygous for DQB1*0602.
Depending on the Aspergillus antigens used for stimulation, a lymphoproliferative response was identified in up to 87% of healthy individuals. The frequencies of Aspergillus-specific T cells varied between 0.24% and 0.91% of CD4+ T cells measured directly ex vivo by intracellular staining for IFN-γ [16] . These rather high percentages of Aspergillus-specific T cells are in contrast with the results of this study, in which no Aspergillus-specific T cells could be identified directly ex vivo after stimulation with synthetic peptides of the A. fumigatus proteins Crf1 and catalase 1, when tested by intracellular staining for CD154 and IFN-γ. Furthermore, we found no or very low frequencies of Aspergillusspecific T cells by means of an Elispot assay, in accordance with the results of Steuhler et al and Khanna et al, who did not detect an IFN-γ response directly ex vivo by Elispot analysis after stimulation with overlapping peptides of Crf1 [12, 19] . However, after stimulation and restimulation with overlapping peptides of Crf1 and catalase 1, we identified low frequencies of Aspergillusspecific T cells, similar to the results of previous studies that used Crf1 synthetic peptides [12, 19] . Frequencies of Aspergillusspecific T cells were stable in an individual at different time points. Furthermore, there were no differences in frequencies, levels of cytokine production, and cytokine profiles between individuals with different HLA types.
The marked difference in frequencies of Aspergillus-specific T cells after stimulation with crude extracts rather than with synthetic peptides can be explained by the number of T-cell target proteins present in the crude extract. In contrast, in the case of stimulation with synthetic peptides, the T-cell response against only 1 A. fumigatus protein is evaluated. Furthermore, T cells can become activated by components in the crude extract or recombinant proteins other than Aspergillus-derived antigens, and therefore higher frequencies of activated and cytokine-producing T cells will be found [6, 8, [16] [17] [18] . Considering the large variety of T-cell epitopes identified after stimulation with the overlapping peptides of Crf1 and catalase 1, these 2 A. fumigatus proteins are important target proteins for the T-cell immune response against Aspergillus. Furthermore, it indicates that the Aspergillus-specific T-cell response is most likely directed against various epitopes of multiple A. fumigatus proteins without one dominant peptide specificity.
Several studies have assessed the presence of Aspergillus-specific T cells after stimulation with overlapping peptides of Crf1. Until now, 15 Aspergillus-specific T-cell epitopes have been described, all from the Crf1 protein [11] [12] [13] . In the present study, 7 Crf1-specific T-cell epitopes were identified, among which are the 2 previously described epitopes at amino acids 161-171 (HTY) and 233-247 (YTM) [12, 13] , although we determined that the HLA restriction of Crf1 epitope at amino acids 161-171 (HTY) was HLA-DRB3*01, in contrast to what was described before [12] .
Besides Crf1-specific T cells in 10 individuals, we found catalase 1-specific T cells in 16 of 24 healthy individuals, recognizing 30 different catalase 1 epitopes. Aspergillus specificity was confirmed for 20 of the epitopes by stimulation with EBVLCLs loaded with catalase 1 recombinant protein. Only the 2 catalase 1-specific T-cell clones with the highest avidity also recognized DCs loaded with A. fumigatus crude extract. These results may indicate that the amount of catalase 1 protein present in the crude extract is very low. However, in the in vivo situation, the catalase 1 protein is expressed, processed, and presented, leading to a catalase 1-specific T-cell immune response, as can be concluded from the isolation of a large variety of catalase 1-specific T cells from several individuals.
By isolating Aspergillus-specific T cells on the basis of CD137, IFN-γ-producing T cells were predominantly obtained. This is in line with previous studies showing that stimulation with Aspergillus conidia resulted in IFN-γ production and almost no IL-17 production [20] , and stimulation with Crf1 recombinant protein resulted in IFN-γ production, no IL-4 production, and low IL-17 production [18] . In our study, the T-cell phenotype did not differ between Crf1-and catalase 1-specific T cells, in contrast to Bozza et al [8] , who found that catalase 1-specific T cells produced IL-4 in addition to IFN-γ, IL-10, and IL-17, whereas no IL-4 production was seen in Crf1-specific T cells. A predominant Th1 inflammatory response against A. fumigatus might reflect the actual in vivo situation or might be a consequence of the selection method by sorting on the basis of CD137 expression. For the generation of an Aspergillus-specific T-cell product suitable for infusion in patients with aspergillosis, it can be an advantage that predominantly IFN-γ-producing T cells are selected, while several studies have found that Th1 cells result in a favorable outcome [5, [7] [8] [9] , in contrast to Th2 [4] and T-helper 17 cells [21, 22] .
In summary, in this study involving healthy individuals, we demonstrate the presence of Aspergillus-specific T cells directed against a large variety of epitopes of the Crf1 and catalase 1 protein. This broad T-cell repertoire against A. fumigatus will make it difficult to select the appropriate T cells for adoptive Tcell therapy on the basis of 1 single peptide specificity. However, by stimulating with overlapping peptides of several A. fumigatus proteins and selecting on the basis of CD137 expression, a T-cell product that has the desired broad repertoire, known specificity, and favorable cytokine profile and is suitable for adoptive T-cell therapy can be generated.
Notes
